Table 1.
Baseline characteristics of enrolled cases.
| Characteristics | TCGA cohort n = 537 No. of patients (%) | ICGC cohort n = 90 No. of patients (%) |
|---|---|---|
| Age ≤65 | 336 (62.57) | 62 (68.89) |
| Male | 346 (64.43) | 51 (56.67) |
| Pathologic_T | ||
| T1 | 275 (51.21) | 54 (60.00) |
| T2 | 69 (12.85) | 13 (14.44) |
| T3 | 182 (33.89) | 21 (23.33) |
| T4 | 11 (2.05) | 2 (2.22) |
| Tx or unknown | 0 | 0 |
| Pathologic_M | ||
| M0 | 426 (79.33) | 81 (90.00) |
| M1 | 79 (14.71) | 8 (8.89) |
| Mx or unknown | 32 (5.96) | 1 (1.11) |
| Pathologic_N | ||
| N0 | 240 (44.69) | 78 (86.67) |
| N1 | 17 (3.17) | 2 (2.22) |
| Unknown | 280 (52.14) | 10 (11.11) |
| Histologic_grade | ||
| G1 | 14 (2.61) | |
| G2 | 230 (42.83) | |
| G3 | 207 (38.55) | |
| G4 | 78 (14.53) | |
| Gx or unknown | 8 (1.49) | |
| Tumor_stage | ||
| Stage I | 269 (50.09) | |
| Stage II | 57 (10.61) | |
| Stage III | 125 (23.28) | |
| Stage IV | 83 (15.46) | |
| Status | ||
| Alive | 360 (67.04) | 61 (67.78) |
| Dead | 177 (32.96) | 29 (32.22) |
| Unknown | 3 (0.56) | 0 |
| Follow-up time | ||
| t ≤365 | 97 (18.06) | 7 (7.78) |
| 1,825 ≥ t > 365 | 290 (54.00) | 42 (46.67) |
| t >1,825 | 150 (27.93) | 41 (45.56) |
ICGC, International Cancer Genome Consortium; TCGA, The Cancer Genome Atlas.